Results - Announcements
Ajanta Pharma Ltd share price ticked higher by 0.24% to Rs 3459.85 after the company's net profit rose by 16.13% to Rs 388.14 crore, while revenue from operations increased 10.34% to Rs 1794.16 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, gaining 4.41%. It has marginally improved by 5.74% over last one week and gained upto 0.60% in last one month while the market capitalization of Ajanta Pharma Ltd has improved by 5.45% and 0.28% in the same period respectively.
Profit before tax (PBT) of Ajanta Pharma Ltd stood at Rs 535.15 crore in Q3 FY26, jumping 57.02% year-on-year, and rallying 19.77% quarter-on-quarter. EBITDA came in at Rs 510 crore, surging by 90.01% YoY and expanding by 44.66% sequentially.
Total expenses inched up 3.79% to Rs 1294.16 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 348.97 crore, going up by 17.69% YoY, while employee benefits expense was at Rs 383.69 crore, ticking higher by 0.68% YoY.
For the TTM ended FY26, revenue from operations rose 17.31% to Rs 5452.86 crore, while net profit registered a growth of 14.73% to Rs 1056.0 crore, compared to previous TTM. EBITDA jumped by 119303% to Rs 1222.76 crore, and PBT improved 15.85% to Rs 1377.65 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 529.19 crore in FY26, as against Rs 1157.23 crore in FY25.
Ajanta Pharma Ltd jumped 40.59% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 12.76% during the same period.